References
- Redman JR, Cabanillas F, Velasquez WS, et al. Phase II trial of fludarabine phosphate in lymphoma: An effective new agent in low-grade lymphoma. J Clin Oncol 1992; 109: 790–794
- Zinzani PL, Bendandi M, Magagnoli M, et al. Fludarabine-mitoxantrone combination-containing regimen in recurrent low-grade non-Hodgkin's lymphoma. Ann Oncol 1997; 8: 379–383
- Colombat P, Donadio D, Fouillard L, et al. Value of autologous bone marrow transplantation in follicular lymphoma. A France Autogreffe retrospective study of 42 patients. Bone Marrow Transplant 1994; 13: 157–162
- Bastion Y, Brice P, Haioun C, et al. Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood 1995; 8: 3257–3262
- Perry AR, Watts MJ, Peniket AJ, Goldstone AH, Linch DC. Progenitor cell yields are frequently poor in patients with histologically indolent lymphomas especially when mobilized within 6 months of previous chemotherapy. Bone Marrow Transplant 1998; 21: 1201–1205
- Watts MJ, Sullivan A.M., Leverett D., et al. Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem-cell mobilization. J Clin Oncology 1998; 4: 1554–1560
- Ketterer N, Salles G, Moullet I, et al. Factors associated with successful mobilisation of peripheral blood progenitor cells in 200 patients with lymphoid malignancies. Br J Haematol 1998; 103: 235–242
- Harris NL, Jaffe ES, Stein H, et al. A Revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
- McQuaker IG, Haynes AP, Stainer C, Anderson S, Russel NH. Stem cell mobilisation in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide. Br J Haematol 1997; 98: 228–233
- To LB, Haylock DN, Simmons PJ, Juttner CA. Blood 1997; 89: 2233–2258
- Bensinger W, Appelbaum E, Rowley S, et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995; 13: 2547–2555
- Clark RE, Brammer CG. Previous treatment predicts the efficiency of blood progenitor cell mobilisation: validation of a chemotherapy scoring system. Bone Marrow Transpl 1998; 22: 859–863
- Sala R, Mauro FR, Bellucci R, et al. Evaluation of marrow and blood haemopoietic progenitors in chronic lymphocytic leukemia before and after chemotherapy. Eur J Haematol 1998; 61: 14–20
- Drake M, Ranaghan L, Morris T CM, et al. Analysis of the effect of prior chemotherapy on progenitor cell yield: use of a chemotherapy scoring system. Br J Haematol 1997; 98: 745–749